Page last updated: 2024-11-05

thalidomide and Community Acquired Infection

thalidomide has been researched along with Community Acquired Infection in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Certan, M1
Garcia Garrido, HM1
Wong, G1
Heijmans, J1
Grobusch, MP1
Goorhuis, A1
Girard, LP1
Gregson, DB1

Other Studies

2 other studies available for thalidomide and Community Acquired Infection

ArticleYear
Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 09-29, Volume: 75, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Cohort Studies; Community-Acquired Infections; D

2022
Community-acquired lung abscess caused by Legionella micdadei in a myeloma patient receiving thalidomide treatment.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:9

    Topics: Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Humans; Immunosuppressive Agents

2007